O'Loughlin Steve
CIK 0001615840
Chief Financial Officer
Filings
3
Latest Mar 4, 2026
Issuers covered
2
Showing
3 of 3
Page 1
Track record
Realized signed returns on open-market buys and sales
No scored trades yet for O'Loughlin Steve. Track record appears once open-market purchases or sales reach the +30 day horizon.
Issuers
Companies where O'Loughlin Steve has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ATNM | Actinium Pharmaceuticals, Inc. | 2 | Apr 2, 2025 |
| CNSP | Cns Pharmaceuticals, Inc. | 1 | Mar 4, 2026 |
All filings
3 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|